Physician profile

Idelma Kulischenko

Internal Medicine · East Brunswick, NJ

NPI 1679527790

$1,657.94

in general payments reported to CMS, 2019-2025

17 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals LP $400.51 2019-2021
Allergan, INC. $267.70 2020
Novo Nordisk INC $169.51 2019-2021
Amarin Pharma, INC. $145.66 2019-2020
Ironwood Pharmaceuticals, INC $124.00 2019
Kyowa Kirin, INC. $121.54 2019
Abbott Laboratories $118.82 2019
Kowa Pharmaceuticals America, INC. $97.28 2020-2021
Biohaven Pharmaceuticals, INC. $75.50 2021
Merck Sharp & Dohme LLC $50.79 2020-2021
Alexion Pharmaceuticals, INC. $14.82 2020
Kaleo, INC. $12.83 2019
Glaxosmithkline, LLC. $12.20 2019
Biodelivery Sciences International, INC. $11.99 2020
Otsuka America Pharmaceutical, INC. $11.88 2019
Show all 17 companies
CompanyGeneral paymentsYearsTop products
Antares Pharma, INC. $11.62 2020
Abbvie INC. $11.29 2021

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Idelma Kulischenko

$1,657.94

in general payments reported 2019-2025

Years
2019-2021
Top company
Astrazeneca Pharmaceuticals LP

https://glasscript.com/doctor/894542/idelma-kulischenko

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.